RenovoRx, Inc.
RenovoRx, Inc. (RNXT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RNXT · as of Jun 9, 2026
Key Statistics
Explore RenovoRx, Inc. Data
rnxt stock data · financialsCompetitors & Peers
rnxt competitorsRNXT
ANVS
BCAB
CALC
CELU
ELUTAbout RenovoRx, Inc.
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative dru…
what is renovorx, inc. · rnxt stock overview · renovorx, inc. company profile · who is renovorx, inc. ceo · rnxt NASDAQ · renovorx, inc. headquarters · renovorx, inc. business segments
About Stock Overview & Key Data
RenovoRx, Inc. (RNXT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 26, 2021. As of the latest trading session, RNXT stock price is $0.90, with a market capitalization of $33.6M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, RenovoRx, Inc. (RNXT) stock price is $0.90. The stock is traded on NASDAQ under the ticker symbol RNXT. The 52-week range is $0.70 – $1.45.